Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews

被引:58
|
作者
Wolfe, Dianna [1 ]
Yazdi, Fatemeh [1 ]
Kanji, Salmaan [1 ,2 ]
Burry, Lisa [3 ]
Beck, Andrew [1 ]
Butler, Claire [1 ]
Esmaeilisaraji, Leila [1 ]
Hamel, Candyce [1 ]
Hersi, Mona [1 ]
Skidmore, Becky [1 ]
Moher, David [1 ,4 ]
Hutton, Brian [1 ,4 ]
机构
[1] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada
[2] Ottawa Hosp, Dept Pharm, Ottawa, ON, Canada
[3] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[4] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
加拿大健康研究院;
关键词
PHYSICIAN ORDER ENTRY; REDUCE MEDICATION ERRORS; REACTION REPORTING SYSTEM; INTENSIVE-CARE; CAUSALITY ASSESSMENT; DECISION-SUPPORT; EVENTS; IMPACT; INTERVENTIONS; METAANALYSIS;
D O I
10.1371/journal.pone.0205426
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Preventable adverse drug reactions (PADRs) in inpatients are associated with harm, including increased length of stay and potential loss of life, and result in elevated costs of care. We conducted an overview of reviews (i.e., a systematic review of systematic reviews) to determine the incidence of PADRs experienced by inpatients. Secondary review objectives were related to assessment of the effects of patient age, setting, and clinical specialty on PADR incidence. Methods The protocol was registered in PROSPERO (CRD42016043220). We performed a search of Medline, Embase, and the Cochrane Library, limiting languages of publication to English and French. We included published systematic reviews that reported quantitative data on the incidence of PADRs in patients receiving acute or ambulatory care in a hospital setting. The full texts of all primary studies for which PADR data were reported in the included reviews were obtained and data relevant to review objectives were extracted. Quality of the included reviews was assessed using the AMSTAR-2 tool. Both narrative summaries of findings and meta-analyses of primary study data were undertaken. Results Thirteen systematic reviews encompassing 37 unique primary studies were included. Across primary studies, the PADR incidence was highly varied, ranging from 0.006 to 13.3 PADRs per 100 patients, with a pooled incidence estimate of 0.59 PADRs per 100 patients. Substantial heterogeneity was present across both reviews and primary studies with respect to review/study objectives, patient age, hospital setting, medical discipline, definitions and assessment tools used, event detection methods, endpoints of interest, and units of measure. Thirteen primary studies used prospective event detection methods and had a pooled PADR incidence of 3.13 (2.87-3.38) PADRs per 100 patients; however, extreme statistical heterogeneity (I-2 = 97%) indicated this finding should be considered with caution. Subgroup meta-analyses demonstrated that PADR incidence varied significantly with event detection method (prospective > retrospective > voluntary reporting methods), hospital setting (ICU > wards), and medical discipline (medical > surgical). High statistical heterogeneity (I-2 > 80%) was present across all analyses, indicating results should be interpreted with caution. Effects of patient age could not be assessed due to poor reporting of age groups used in primary studies. Discussion The method of event detection appeared to significantly influence PADR incidence, with prospective methods having the highest reported PADR rate. This finding is in agreement with the background literature. High methodological and statistical heterogeneity across primary studies evaluating adverse drug events reduces the validity of the overall PADR incidence derived from the meta-analyses of the pooled data. Data pooled from studies using only prospective methods of event detection should provide an overall estimate closest to the true PADR incidence; however, our estimate should be considered with caution due to the statistical heterogeneity found in this group of studies. Future studies should employ prospective methods of detection. This review demonstrates that the true overall incidence of PADRs is likely much greater than the overall pooled incidence estimate of 0.59 PADRs per 100 patients obtained when event detection method was not taken into consideration.
引用
收藏
页数:36
相关论文
共 50 条
  • [41] Methods for the detection of adverse drug reactions in hospitalized children: a systematic review
    Ramos, Sheila Feitosa
    Alvarez, Nathalia Rodrigues
    dos Santos Alcantara, Thaciana
    Sanchez, Julia Mirao
    da Costa Lima, Elisangela
    de Lyra Junior, Divaldo Pereira
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (10) : 1225 - 1236
  • [42] Methods for identifying adverse drug reactions in primary care: A systematic review
    Logan, Vera
    Hughes, David
    Turner, Adam
    Carter, Neil
    Jordan, Sue
    PLOS ONE, 2025, 20 (02):
  • [43] Quality of life in children with adverse drug reactions: a narrative and systematic review
    Del Pozzo-Magana, Blanca R.
    Rieder, Michael J.
    Lazo-Langner, Alejandro
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 827 - 833
  • [44] Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
    Skokou, Maria
    Karavia, Eleni A.
    Drakou, Zoi
    Konstantinopoulou, Vassiliki
    Kavakioti, Christina-Anna
    Gourzis, Philippos
    Kypreos, Kyriakos E.
    Andreopoulou, Ourania
    PHARMACEUTICALS, 2022, 15 (07)
  • [45] Factors affecting patient reporting of adverse drug reactions: a systematic review
    Al Dweik, Rania
    Stacey, Dawn
    Kohen, Dafna
    Yaya, Sanni
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) : 875 - 883
  • [46] Potential role of pharmacogenomics in reducing adverse drug reactions - A systematic review
    Phillips, KA
    Veenstra, DL
    Oren, E
    Lee, JK
    Sadee, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2270 - 2279
  • [47] A systematic review of observational studies evaluating costs of adverse drug reactions
    Marques, Francisco Batel
    Penedones, Ana
    Mendes, Diogo
    Alves, Carlos
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 413 - 426
  • [48] Determinants of Under-Reporting of Adverse Drug Reactions A Systematic Review
    Lopez-Gonzalez, Elena
    Herdeiro, Maria T.
    Figueiras, Adolfo
    DRUG SAFETY, 2009, 32 (01) : 19 - 31
  • [49] Adverse drug reactions in elderly patients with cognitive disorders: A systematic review
    Kanagaratnam, Lukshe
    Drame, Moustapha
    Trenque, Thierry
    Oubaya, Nadia
    Nazeyrollas, Pierre
    Novella, Jean-Luc
    Jolly, Damien
    Mahmoudi, Rachid
    MATURITAS, 2016, 85 : 56 - 63
  • [50] Ethnic differences in adverse drug reactions to asthma medications: a systematic review
    Hu, Yusun
    Cantarero-Arevalo, Lourdes
    JOURNAL OF ASTHMA, 2016, 53 (01) : 69 - 75